Life Technologies reported $-259000 in EBITDA for its fiscal quarter ending in June of 2025.


Ebitda Change Date
Ardelyx USD -11872000 20.51M Jun/2025
Biogen USD 1.01B 456.5M Jun/2025
Bristol-Myers Squibb USD 3.27B 1.63B Jun/2025
Cipla INR 17.78B 2.41B Jun/2025
Clal Biotechnology ILS -5295000 2.09M Dec/2022
Compugen -8429000 946K Jun/2025
CSL USD 3.23B 1.52B Dec/2024
Galapagos EUR -158708000 177.84M Mar/2025
GlaxoSmithKline GBP 3.18B 45M Jun/2025
Grifols EUR 536.1M 71.58M Dec/2024
Life Technologies USD -259000 15.39M Jun/2025
Novartis USD 6.17B 339M Jun/2025
Roche Holding CHF 12.68B 2.36B Jun/2024
United Therapeutics USD 436.8M 34.2M Jun/2025